Skip to main content
Premium Trial:

Request an Annual Quote

Orchid Receives Approval to Use SNP Technology as Primary Markers for Paternity Testing

NEW YORK, May 7 – Orchid BioSciences announced today approval from the American Association of Blood Banks to use single nucleotide polymorphisms as stand-alone geneitic markers in its paternity testing operations.

 

Orchid is replacing conventional short tandem repeat technology with its SNP genotyping technology in its paternity testing operations. 

 

The company said that, with the AABB approval in hand, it will deploy its SNP technology throughout its US lab operations and expects the technology to be implemented before the end of the year.
The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.